Literature DB >> 17062852

Industry, FDA warm to "adaptive" trials.

Bridget M Kuehn.   

Abstract

Mesh：

Year:  2006        PMID： 17062852     DOI： 10.1001/jama.296.16.1955

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Clinical research methodology I: introduction to randomized trials.

Authors:  Lillian S Kao; Jon E Tyson; Martin L Blakely; Kevin P Lally
Journal:  J Am Coll Surg       Date:  2008-02       Impact factor: 6.113

Review 2.  Comorbidity in older adults with cancer.

Authors:  Grant R Williams; Amy Mackenzie; Allison Magnuson; Rebecca Olin; Andrew Chapman; Supriya Mohile; Heather Allore; Mark R Somerfield; Valerie Targia; Martine Extermann; Harvey Jay Cohen; Arti Hurria; Holly Holmes
Journal:  J Geriatr Oncol       Date:  2015-12-22       Impact factor: 3.599

3.  Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).

Authors:  Mei Lu; Svend O Freytag; Hans Stricker; Jae Ho Kim; Kenneth Barton; Benjamin Movsas
Journal:  Contemp Clin Trials       Date:  2011-02-12       Impact factor: 2.226

4.  First-in-human trial participants: not a vulnerable population, but vulnerable nonetheless.

Authors:  Rebecca Dresser
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718

Review 5.  Emerging concepts in acute kidney injury following cardiac surgery.

Authors:  Christopher Hudson; Jordan Hudson; Madhav Swaminathan; Andrew Shaw; Mark Stafford-Smith; Uptal D Patel
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2008-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.